Association of herpes zoster infection with clinical characteristics and MBL2 gene polymorphisms in chinese children with systemic lupus erythematosus

Pediatric Infectious Disease Journal

Volumn 30, Issue 8, 2011, Pages 656-660

  Wu, Shun An ^a   Yeh, Kou Wei ^a   Yao, Tsung Chieh ^a   Huang, Jing Long ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

children; herpes zoster; mannose binding lectin; systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; MANNOSE BINDING LECTIN 2; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ADOLESCENT; ARTICLE; CHILD; CHINESE; CODON; COMPARATIVE STUDY; DRUG PULSE THERAPY; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HERPES ZOSTER; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN;

EID: 79960642114     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182127b67     Document Type: Article

References (35)

1. Weller TH. Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus. N Engl J Med. 1983;309:1362-1368.
2. Lee PP, Lee TL, Ho MH, et al. Herpes zoster in juvenile-onset systemic lupus erythematosus incidence, clinical characteristics and risk factors. Pediatr Infect Dis J. 2006;25:728-732. (Pubitemid 44162131)
3. Pope JE, Krizova A, Ouimet JM, et al. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: casecontrol study of patients with SLE or noninflammatory musculoskeletal disorders. J Rheumatol. 2004;31:274-279. (Pubitemid 38160748)
4. Ishikawa O, Abe M, Miyachi Y. Herpes zoster in Japanese patients with systemic lupus erythematosus. Clin Exp Dermatol. 1999;24:327-328. (Pubitemid 29366918)
5. Huang JL, Lin GJ, Hung IJ. Morbidity and mortality associated with childhood systemic lupus erythematosus. Chang Gung Med J. 1994;17: 113-120.
6. Kakourou T, Theodoridou M, Mostrou G, et al. Herpes zoster in children. J Am Acad Dermatol. 1998;39:207-210. (Pubitemid 28367330)
7. Neth O, Jack DL, Dodds AW, et al. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun. 2000;68:688-693. (Pubitemid 30056524)
8. Tsai YC, Yao TC, Kuo ML, et al. Lack of association of mannose-binding lectin gene polymorphisms with development and clinical manifestations of systemic lupus erythematosus in Chinese children. Lupus. 2008;18:372-376.
9. Castro J, Balada E, Ordi-Ros J, et al. The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev. 2008;7:345-351.
10. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol. 2004; 22:431-456. (Pubitemid 38680429)
11. Nauta AJ, Raaschou-Jensen N, Roos A, et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol. 2003; 33:2853-2863. (Pubitemid 37337151)
12. Tsutsumi A, Takahashi R, Sumida T. Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev. 2005;4:364-372. (Pubitemid 41080073)
13. Garred P, Larsen F, Seyfarth J, et al. Mannose-binding lectin and its genetic variants. Genes Immun. 2006;7:85-94. (Pubitemid 43336050)
14. Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity. Hum Immunol. 2006;67:247-256. (Pubitemid 43729357)
15. McDonald JR, Zeringue AL, Caplan L, et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis. 2009;48:1364.
16. Garred P, Voss A, Madsen HO, et al. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun. 2001;2: 442-450. (Pubitemid 33674263)
17. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25: 1271-1277. (Pubitemid 13221242)
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
19. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients: the Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630-640.
20. Park HB, Kim KC, Park JH, et al. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus. J Rheumatol. 2004; 31:2151-2155.
21. Nagasawa K, Yamauchi Y, Tada Y, et al. High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis. 1990;49:630-633. (Pubitemid 20225437)
22. Kahl LE. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol. 1994;21:84-86. (Pubitemid 24044923)
23. Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol. 2003;15:528-534. (Pubitemid 37041388)
24. Manzi S, Kuller LH, Kutzer J, et al. Herpes zoster in systemic lupus erythematosus. J Rheumatol. 1995;22:1254-1258.
25. Illei GG, Austin HA, Crane M, et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med. 2001;135:248-257. (Pubitemid 32799338)
26. Ginzler E, Diamond H, Kaplan D, et al. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 1978;21:37-44. (Pubitemid 9127950)
27. Karim MY, Alba P, Cuadrado MJ, et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford). 2002;41:876-882.
28. Grose C, Giller RH. Varicella-zoster virus infection and immunization in the healthy and the immunocompromised host. Crit Rev Oncol Hematol. 1988;8:27-64. (Pubitemid 18064951)
29. Saifuddin M, Hart ML, Gewurz H, et al. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol. 2000;81:949-955. (Pubitemid 30189633)
30. Mangano A, Rocco C, Marino SM, et al. Detrimental effects of mannosebinding lectin (MBL2) promoter genotype XA/XA on HIV-1 vertical transmission and AIDS progression. J Infect Dis. 2008;198:694-700.
31. Ribeiro LZ, Tripp RA, Rossi LM, et al. Serum mannose-binding lectin levels are linked with respiratory syncytial virus disease. J Clin Immunol. 2008;28:166-173. (Pubitemid 351328951)
32. Zhang H, Zhou G, Zhi L, et al. Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis. 2005;192:1355-1361. (Pubitemid 41401148)
33. Seppänen M, Lokki ML, Lappalainen M, et al. Mannose-binding lectin 2 gene polymorphism in recurrent herpes simplex virus 2 infection. Hum Immunol. 2009;70:218-221.
34. Juul-Madsen HR, Munch M, Handberg KJ, et al. Serum levels of mannanbinding lectin in chickens prior to and during experimental infection with avian infectious bronchitis virus. Poult Sci. 2003;82:235-241. (Pubitemid 38641979)
35. Grarred P, Madsen HO, Halberg P. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum. 1999;42:2145-2152. (Pubitemid 30263598)